Soliris (eculizumab)

pCPA File Number: 21270
Negotiation Status:
Concluded without agreement
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Alexion Pharma GMBH
CDA-AMC Project Number:
SR0640-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: